Massive antibody mining, an unique platform for accelerating R&D timeline of therapeutic antibodies.
Proprietary Topo-Antibody® with global epitope coverage combines with digital immortalization facilitate accelerated timeline for the development of new antibody therapeutics.
Recombinant protein as a Pan Fc Receptor Interacting molecule
Cancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.
Massive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.
Niche platform technology for life cycle maintenance of approved antibody drugs.
Next generation CAR-T modules.